Halotestin vs Melanotan II
Well Studied vs Well Studied
monitor Mechanism-based · 51% Both Halotestin and Melanotan II can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar).
Molecular Data
Halotestin Melanotan II
Weight 336.44 Da —
Half-life ~9.5 hours ~2 hours
Type 9-fluoro-11-beta-hydroxy-17-alpha-methyltestosterone (C20H29FO3) Synthetic alpha-MSH analog
Key Benefits
Halotestin
01 Dramatic increase in strength and power output without water retention
02 Pronounced increase in aggression and competitive drive
03 Does not aromatize to estrogen, producing a hard and dry appearance
04 Enhances red blood cell production and oxygen-carrying capacity
05 Rapid onset of effects, typically noticeable within days
06 Uniquely suited for pre-competition or pre-meet peaking protocols
07 Short cycle duration limits cumulative exposure
Melanotan II
01 Rapid tanning without UV exposure
02 Enhanced sexual function and libido
03 Appetite suppression
04 Improved mood via melanocortin activation
05 Photoprotection through increased melanin
Dosing Protocols
Halotestin
10-20 mg/day / Split into 2 doses daily (morning and pre-training)
Melanotan II
Loading: Start 0.25mg daily, increase to 0.5-1mg; Maintenance: 0.5-1mg 2-3x weekly / Loading phase: Daily for first week, then tanning maintenance 2-3x weekly or as needed for sexual enhancement
Initial loading phase 0.25mg 1x daily
Tanning maintenance 0.5-1mg 2-3x weekly
Sexual enhancement 0.5-1mg As needed
Minimal side effects 0.1-0.25mg Every other day
Photoprotection 0.5mg 2x weekly
Side Effects
Halotestin
Severe hepatic stress (elevated ALT, AST, GGT, bilirubin)
Pronounced aggression and irritability
HDL cholesterol suppression and LDL elevation
Elevated blood pressure
Headaches (frequently reported, may be related to blood pressure changes)
Suppression of endogenous testosterone production
Oily skin and acne
Decreased appetite (potentially related to liver stress)
Melanotan II
Nausea (pre-treatment with antiemetics recommended)
Facial flushing
Temporary blood pressure elevation
Fatigue
Spontaneous erections
Contraindications
Known or suspected prostate cancer
Breast cancer in males
Pregnancy (Category X - causes fetal harm)
Active liver disease or existing hepatic impairment
Severe cardiovascular disease or uncontrolled hypertension
Hypercalcemia
Nephrosis or nephrotic phase of nephritis
History of cholestatic jaundice or hepatic dysfunction from prior anabolic steroid use
Hypersensitivity to fluoxymesterone or any formulation component
History of melanoma or dysplastic nevi
Pregnancy or breastfeeding
Cardiovascular conditions
Uncontrolled hypertension
Research Evidence
Halotestin Melanotan II
Status Well Studied Well Studied
References 5 studies 4 studies
Latest October 2023 2024
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.